Perkins Coie advised the government of India on the creation and initial public offering of its first central public sector enterprise (CPSE) exchange traded fund (ETF) on the National Stock Exchange. The ETF raised more than Rs 3000 crore (approximately US$501 million) in its initial public offering. The ETF will purchase and hold stakes in 10 selected central public sector companies (PSCs) through a mutual fund format.
Tags: Perkins Coie LLPShearman & Sterling Advises on $3 Billion Refinancing for IntercontinentalExchange
Shearman & Sterling advised IntercontinentalExchange Group Inc. (“ICE”) in connection with a $3 billion five-year multicurrency revolving credit facility that refinances ICE’s existing five-year and 364-day facilities arranged by Wells Fargo Securities, LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, The Bank of Tokyo-Mitsubishi UFJ, Ltd., Bank of China, New York Branch, BMO Capital Markets Corp., BBVA Compass Bank, Fifth Third Bank, Regions Bank N.A. and Suntrust Robinson Humphrey, Inc.
Tags: Shearman & Sterling LLPSimpson Thacher Represents Blackstone Holdings Finance Co. L.L.C in $500 Million Senior Notes Offering
Simpson Thacher recently represented Blackstone Holdings Finance Co. L.L.C., an indirect finance subsidiary of The Blackstone Group L.P., in its issuance and sale of $500,000,000 aggregate principal amount of 5.000% Senior Notes due 2044. The notes are guaranteed by The Blackstone Group L.P., Blackstone Holdings I L.P., Blackstone Holdings II L.P., Blackstone Holdings III L.P. and Blackstone Holdings IV L.P. The company intends to use the net proceeds for general corporate purposes.
Tags: Simpson Thacher & Bartlett LLPShearman & Sterling Advises Sun Pharmaceutical Industries on $4 Billion Acquisition of Ranbaxy
Shearman & Sterling is advising Sun Pharmaceutical Industries Ltd. on its acquisition of Ranbaxy Laboratories Ltd. in a transaction valued at $4 billion. The closing of the transaction will be subject to customary closing conditions, including approval by the Indian Central Government, approval by the High Courts of Gujarat and Punjab and Haryana, approval by the Competition Commission of India and expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act in the United States. Pending approvals, Sun Pharma anticipates that the transaction will close by the end of calendar year 2014.
Tags: Shearman & Sterling LLPWhite & Case Advises Japanese Banks on €1.28 Billion Debt Refinancing for Joint Acquisition by LIXIL Corporation and DBJ of Controlling Stake in Grohe Group
Global law firm White & Case LLP has advised The Bank of Tokyo-Mitsubishi UFJ, Ltd, Sumitomo Mitsui Banking Corporation and Mizuho Bank, Ltd on the €1.28 billion refinancing of the debt provided to the LIXIL Corporation and the Development Bank of Japan Inc. for their joint acquisition of 87.5 percent of the share capital in GROHE Group S.à r.l.. More >>
Tags: White & Case LLPCincinnati Bell’s Sale of Wireless Spectrum Licenses to Verizon Wireless
Cincinnati Bell, a leader in telecommunications and broadband networking services, announced that it has entered into agreements to sell its wireless spectrum licenses and certain related assets to Verizon Wireless for cash and an assumption of certain Cincinnati Bell liabilities with a total value to Cincinnati Bell of approximately US$210 million. Cravath represented Cincinnati Bell in connection with this transaction, which is expected to close in the second half of 2014, subject to customary closing conditions.
Shearman & Sterling Advises Sun Pharmaceutical Industries on $4 Billion Acquisition of Ranbaxy
Shearman & Sterling is advising Sun Pharmaceutical Industries Ltd. on its acquisition of Ranbaxy Laboratories Ltd. in a transaction valued at $4 billion. The closing of the transaction will be subject to customary closing conditions, including approval by the Indian Central Government, approval by the High Courts of Gujarat and Punjab and Haryana, approval by the Competition Commission of India and expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act in the United States. Pending approvals, Sun Pharma anticipates that the transaction will close by the end of calendar year 2014.
Tags: Shearman & Sterling LLPSimpson Thacher Represents Centerview Partners, Financial Advisor to Questcor Pharmaceuticals, in Mallinckrodt’s Acquisition of Questcor Pharmaceuticals for Approximately $5.6 Billion
The Firm is representing Centerview Partners LLC in its role as financial advisor to Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) in connection with Mallinckrodt plc’s (NYSE: MNK) definitive agreement to acquire Questcor for a combination of cash and equity valued at, based on Mallinckrodt’s pre-announcement closing price, approximately $5.6 billion. In the proposed transaction, shareholders of Questcor will receive $30.00 in cash and 0.897 shares of Mallinckrodt for each share of Questcor. According to the parties, the transaction is subject to customary closing conditions, including approval of the shareholders of both companies and Hart-Scott-Rodino clearance in the United States, and is currently expected to be completed in the third calendar quarter of 2014.
Tags: Simpson Thacher & Bartlett LLPKirkland & Ellis LLP Achieves $5.15 Billion Settlement for Tronox Environmental and Tort Creditors
On April 3, 2014, the Anadarko Litigation Trust and the United States reached an historic $5.15 billion settlement with Anadarko Petroleum Corporation to resolve the lawsuit that Kirkland & Ellis filed and successfully prosecuted challenging Kerr-McGee Corporation’s spin-off of Tronox in 2005 as a fraudulent transfer. This is the largest environmental enforcement recovery ever by the Department of Justice. On December 12, 2012, Judge Allan Gropper of the U.S. Bankruptcy Court for the Southern District of New York issued a 166-page opinion finding Kerr-McGee liable for actual and constructive fraudulent transfer.
Tags: Kirkland & Ellis LLPPaul Hastings Represents Joint Book Runners in Blackstone Mortgage Trust, Inc.’s $255 Million Follow-on Public Offering of Class A Common Stock
Paul Hastings LLP, a leading global law firm, announced today that the firm represented Citigroup, BofA Merrill Lynch, J.P. Morgan, Wells Fargo Securities and Morgan Stanley as joint book-running managers for Blackstone Mortgage Trust, Inc.’s (NYSE: BXMT) public offering of class A common stock. More >>
Tags: Paul Hastings, LLP